Capital Analysts LLC’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $74K | Sell |
1,028
-27
| -3% | -$2.08K | ﹤0.01% | 863 |
|
|
2025
Q4 | $84K | Sell |
1,055
-9
| -0.8% | -$710 | ﹤0.01% | 805 |
|
|
2025
Q3 | $80K | Sell |
1,064
-167
| -14% | -$11.4K | ﹤0.01% | 785 |
|
|
2025
Q2 | $85K | Buy |
1,231
+171
| +16% | +$11.2K | ﹤0.01% | 710 |
|
|
2025
Q1 | $72K | Sell |
1,060
-2,802
| -73% | -$168K | ﹤0.01% | 714 |
|
|
2024
Q4 | $173K | Sell |
3,862
-74,866
| -95% | -$4.2M | 0.01% | 514 |
|
|
2024
Q3 | $4.95M | Buy |
78,728
+3,694
| +5% | +$216K | 0.2% | 94 |
|
|
2024
Q2 | $4.43M | Sell |
75,034
-2,715
| -3% | -$170K | 0.2% | 97 |
|
|
2024
Q1 | $6.2M | Buy |
77,749
+2,612
| +3% | +$200K | 0.29% | 77 |
|
|
2023
Q4 | $5.93M | Sell |
75,137
-144
| -0.2% | -$10.2K | 0.3% | 77 |
|
|
2023
Q3 | $5.26M | Buy |
75,281
+371
| +0.5% | +$26.3K | 0.29% | 79 |
|
|
2023
Q2 | $5.18M | Buy |
74,910
+47,249
| +171% | +$3.36M | 0.29% | 78 |
|
|
2023
Q1 | $2.06M | Buy |
27,661
+1,173
| +4% | +$98.4K | 0.12% | 154 |
|
|
2022
Q4 | $2.47M | Buy |
26,488
+94
| +0.4% | +$9.07K | 0.15% | 135 |
|
|
2022
Q3 | $2.52M | Buy |
26,394
+1,654
| +7% | +$164K | 0.17% | 118 |
|
|
2022
Q2 | $2.29M | Buy |
24,740
+1,019
| +4% | +$99.5K | 0.16% | 132 |
|
|
2022
Q1 | $2.4M | Sell |
23,721
-1,086
| -4% | -$114K | 0.15% | 133 |
|
|
2021
Q4 | $2.56M | Buy |
24,807
+958
| +4% | +$88.5K | 0.16% | 132 |
|
|
2021
Q3 | $2.02M | Buy |
23,849
+154
| +0.6% | +$12.9K | 0.13% | 146 |
|
|
2021
Q2 | $1.98M | Buy |
23,695
+59
| +0.2% | +$4.83K | 0.13% | 146 |
|
|
2021
Q1 | $1.78M | Buy |
23,636
+1,336
| +6% | +$97.3K | 0.12% | 155 |
|
|
2020
Q4 | $1.52M | Sell |
22,300
-2,168
| -9% | -$141K | 0.13% | 138 |
|
|
2020
Q3 | $1.43M | Sell |
24,468
-342
| -1% | -$21.3K | 0.14% | 137 |
|
|
2020
Q2 | $1.61M | Sell |
24,810
-470
| -2% | -$29.6K | 0.17% | 110 |
|
|
2020
Q1 | $1.5M | Buy |
25,280
+1,067
| +4% | +$71.2K | 0.18% | 99 |
|
|
2019
Q4 | $1.8M | Sell |
24,213
-672
| -3% | -$47.2K | 0.18% | 109 |
|
|
2019
Q3 | $1.57M | Buy |
24,885
+1,117
| +5% | +$66.2K | 0.17% | 112 |
|
|
2019
Q2 | $1.29M | Buy |
23,768
+1,247
| +6% | +$67.2K | 0.14% | 136 |
|
|
2019
Q1 | $1.21M | Buy |
22,521
+2,507
| +13% | +$155K | 0.14% | 131 |
|
|
2018
Q4 | $1.31M | Buy |
20,014
+532
| +3% | +$39.7K | 0.17% | 101 |
|
|
2018
Q3 | $1.53M | Sell |
19,482
-8
| -0% | -$572 | 0.17% | 102 |
|
|
2018
Q2 | $1.25M | Buy |
19,490
+18,319
| +1,564% | +$1.21M | 0.15% | 113 |
|
|
2018
Q1 | $73K | Buy |
1,171
+318
| +37% | +$22.8K | 0.01% | 269 |
|
|
2017
Q4 | $62K | Sell |
853
-81
| -9% | -$5.89K | 0.01% | 296 |
|
|
2017
Q3 | $76K | Sell |
934
-70
| -7% | -$5.54K | 0.01% | 269 |
|
|
2017
Q2 | $80.8K | Sell |
1,004
-30,702
| -97% | -$2.42M | 0.01% | 264 |
|
|
2017
Q1 | $2.49M | Buy |
31,706
+1,120
| +4% | +$89.4K | 0.39% | 69 |
|
|
2016
Q4 | $2.41M | Sell |
30,586
-25,244
| -45% | -$2.04M | 0.42% | 69 |
|
|
2016
Q3 | $4.97M | Buy |
55,830
+1,515
| +3% | +$143K | 0.93% | 21 |
|
|
2016
Q2 | $5.2M | Buy |
54,315
+1,643
| +3% | +$164K | 1.05% | 18 |
|
|
2016
Q1 | $5.46M | Buy |
52,672
+1,957
| +4% | +$190K | 1.1% | 17 |
|
|
2015
Q4 | $4.96M | Sell |
50,715
-48,315
| -49% | -$4.73M | 1.01% | 18 |
|
|
2015
Q3 | $9.55M | Buy |
99,030
+48,646
| +97% | +$5.11M | 1.83% | 10 |
|
|
2015
Q2 | $5.28M | Buy |
50,384
+982
| +2% | +$100K | 1.08% | 17 |
|
|
2015
Q1 | $5.1M | Sell |
49,402
-1,961
| -4% | -$198K | 1.06% | 16 |
|
|
2014
Q4 | $4.95M | Sell |
51,363
-4,627
| -8% | -$408K | 1.09% | 15 |
|
|
2014
Q3 | $4.46M | Buy |
55,990
+3,785
| +7% | +$298K | 1.05% | 15 |
|
|
2014
Q2 | $3.93M | Sell |
52,205
-804
| -2% | -$60.8K | 0.96% | 16 |
|
|
2014
Q1 | $3.97M | Sell |
53,009
-3,638
| -6% | -$257K | 1.04% | 16 |
|
|
2013
Q4 | $4.05M | Buy |
56,647
+2,429
| +4% | +$156K | 1.1% | 17 |
|
|
2013
Q3 | $3.08M | Sell |
54,218
-2,361
| -4% | -$141K | 0.92% | 20 |
|
|
2013
Q2 | $3.24M | Buy |
+56,579
| New | +$3.28M | 1.02% | 17 |
|
Other funds holding CVS
VCM
VPM
Capital Analysts LLC's CVS Position: Q1 2026 in Review
Capital Analysts LLC reduced its CVS Health (CVS) stake by 2.6% in Q1 2026, selling an estimated $2.08K and leaving 1,028 shares worth $74K. The position accounts for ﹤0.01% of the portfolio, ranked #863.
Capital Analysts LLC first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.55M in Q3 2015. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Capital Analysts LLC held 1,028 shares of CVS Health worth $74K as of Q1 2026.
- Capital Analysts LLC sold 27 CVS Health shares in Q1 2026, an estimated $2.08K.
- CVS Health made up ﹤0.01% of Capital Analysts LLC's portfolio in Q1 2026, its #863 holding.
- Capital Analysts LLC first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
- Capital Analysts LLC's CVS Health position peaked at $9.55M in Q3 2015.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Capital Analysts LLC's 13F filing for Q1 2026, filed 14 May 2026.